Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coupang Inc (CPNG) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Coupang IncTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Coupang Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Coupang Inc trades at $15.82 (market cap $27.70B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Coupang Inc is far larger — about 4.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coupang Inc for 55 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

CPNGIOVA
Market Cap
$27.70B$6.04B
Volume
27,703,60814,805,993
Sector
Consumer CyclicalHealth
52-Week High
$32.13$14.82
52-Week Low
$13.75$1.81
Typical Hold Time
55 Days0 Days
Enterprise Value
$27.22B$5.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coupang Inc

Coupang (CPNG) trades at $15.41, up 4.05% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical outlook with support at $15 and resistance at $16. Fundamentally, revenue grew to $34.53B in 2025 with positive net income of $208M, though profitability metrics remain challenged with negative ROE and high P/E ratio. Analyst sentiment remains overwhelmingly positive with 87.5% buy ratings and a $25.25 consensus price target.

Coupang presents a growth opportunity with dominant South Korean market position and expanding logistics network, but faces execution risks from recent earnings disappointments and competitive pressures. The significant gap between current price and analyst targets suggests upside potential, though investors must weigh high valuation multiples against profitability challenges and geopolitical risks highlighted in recent US-Korea trade tensions.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CPNG
100% Buy0% Sell
Avg holding period · 55 Days
IOVA
51% Buy49% Sell
Avg holding period · 0 Days

About Coupang Inc

Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.

Read more on CPNG →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →